VDF FutureCeuticals Inc.

MOMENCE, Ill.—The concept of focusing on blood markers, rather than diseases, presents new opportunities for the development of novel and efficacious functional foods and nutritionals. Diagnostically developed products can be highly provocative since, without making any disease claims, they can provide actual, quantifiable measures of quality and potency, and demonstrable ability to modulate blood markers/targets that are medically associated with development of chronic conditions. Zbigniew Pietrzkowski, Ph.D., vice president of research and development, will outline the opportunities.

The VendorWorks presentation will be given Friday, Oct. 20, from 8 to 8:50 a.m. at SupplySide West. For more information, visit www.futureceuticals.com or Booth #4067.